secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001437749-22-027413
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q3 revenues up 6% to $1.4M, net loss widens to $2.4M; FY22 guidance cut to $7-9M
--------------------------------------------------------------------------------

- Q3 revenue $1.4M (+6% YoY); YTD revenue $5.3M (+26%) on higher software and service fees.
- Net loss $2.4M ($0.29/share) vs loss of $1.0M ($0.13) in Q3'21; SG&A up $1.1M.
- Full-year 2022 revenue guidance lowered to $7M-$9M (37%-76% growth) citing slower sales and Africa delays.
- Gross margin fell to 71% from 77% due to third-party software costs from Swivel Secure acquisition.
- Cash $2.8M; current assets $9.9M; stockholders' equity $11.2M ($1.32/share) at Sept 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774922027413/0001437749-22-027413-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774922027413/bkyi20221114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-027413

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer